Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase NA 1Phase 4 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Keratosis, Actinic 3Skin Neoplasms 1Carcinoma, Basal Cell 1Bowen's Disease 1

Interventions

Curettage 4Biopsy 4Tomography, Optical Coherence 3Standard of Care 3Mohs Surgery 3Microscopy, Confocal 3Surgical Procedures, Operative 2Cryotherapy 2Acitretin 2sonidegib 1methyl 5-aminolevulinate 1Watchful Waiting 1Vitamin D 1Ultrasonography, Doppler 1Second Harmonic Generation Microscopy 1Risk Factors 1Radiotherapy 1Practice Guidelines as Topic 1Polymerase Chain Reaction 1Photochemotherapy 1Observation 1Mindfulness 1Midazolam 1Methylation 1Melphalan 1Mass Screening 1Laser Therapy 1Laser Speckle Contrast Imaging 1Itraconazole 1Isotretinoin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Carcinoma, Basal Cell × methyl 5-aminolevulinate × Clear all
NCT01482104 2017-10-27

New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC)

Norwegian University of Science and Technology

Phase NA Completed
277 enrolled
Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡